Global Dry Powder Inhalation Medication Supply, Demand and Key Producers, 2024-2030
The global Dry Powder Inhalation Medication market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Dry powder inhaler (DPI), also known as inhalation powder mist, refers to the solid micronized raw material drug alone or mixed with a suitable carrier, in the form of capsules, vesicles or multi-dose storage, using a specially made dry powder for inhalation A device in which the patient actively inhales aerosolized medication into the lungs. It has decades of research history abroad, and most of the drugs currently on the market are used to treat asthma and chronic obstructive pulmonary disease.
This report studies the global Dry Powder Inhalation Medication production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dry Powder Inhalation Medication, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dry Powder Inhalation Medication that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dry Powder Inhalation Medication total production and demand, 2019-2030, (K Units)
Global Dry Powder Inhalation Medication total production value, 2019-2030, (USD Million)
Global Dry Powder Inhalation Medication production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dry Powder Inhalation Medication consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Dry Powder Inhalation Medication domestic production, consumption, key domestic manufacturers and share
Global Dry Powder Inhalation Medication production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Dry Powder Inhalation Medication production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Dry Powder Inhalation Medication production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Dry Powder Inhalation Medication market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmaxis Ltd., AstraZeneca, GSK, Novartis, Gilead Sciences, Boehringer Ingelheim, ORION CORPORATION, Teva Pharmaceuticals and TFF Pharmaceuticals Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dry Powder Inhalation Medication market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Dry Powder Inhalation Medication Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Dry Powder Inhalation Medication Market, Segmentation by Type
Single Dose
Multiple Doses
Storage Type
Global Dry Powder Inhalation Medication Market, Segmentation by Application
Asthmatic
COPD
Other
Companies Profiled:
Pharmaxis Ltd.
AstraZeneca
GSK
Novartis
Gilead Sciences
Boehringer Ingelheim
ORION CORPORATION
Teva Pharmaceuticals
TFF Pharmaceuticals Inc.
Sunovion Pharmaceuticals
Pfizer
Eli Lilly and Company
Key Questions Answered
1. How big is the global Dry Powder Inhalation Medication market?
2. What is the demand of the global Dry Powder Inhalation Medication market?
3. What is the year over year growth of the global Dry Powder Inhalation Medication market?
4. What is the production and production value of the global Dry Powder Inhalation Medication market?
5. Who are the key producers in the global Dry Powder Inhalation Medication market?